Topics

Glioblastoma | Treatment | Clinical trials | Vaccines

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Vaccines

Galanis E, Dooley KE, Keith Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ, Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC, Giannini C, Raghunathan A, Iankov ID, Parney IF.
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Nat Commun. 2024 Jan 12;15(1):493. doi: 10.1038/s41467-023-43076-7. PMID: 38216554. Interventional study. ˍ

Muragaki Y, Ishikawa E, Tamura M, Kawamata T, Gosho M, Hashimoto K, Komori T, Yokoo H, Matsutani M, Maebayashi K, Tanaka T, Yamaguchi S, Kanamori M, Yamamoto T, Hanihara M, Arakawa Y, Sasayama T, Abe T, Nakamura H, Mukasa A, Uzuka T, Nakajo K, Ohno T.
A randomized, placebo-controlled phase III trial of an autologous, formalin-fixed tumor vaccine for newly diagnosed glioblastoma: trial protocol.
Jpn J Clin Oncol. 2025 May 16:hyaf078. doi: 10.1093/jjco/hyaf078. PMID: 40377260. Interventional study protocol˰ ˍ

Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA, LaRocca RV, Aiken RD, Taylor TH, Abedi M, Robles RM, Godding K, Keirstead HS, Nistor GI, Dillman RO.
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.
Hum Vaccin Immunother. 2025 Sep 12;21(1):2556591. doi: 10.1080/21645515.2025.2556591. PMID: 40938661. Interventional study. ˍ

Jha R, Spanehl L, Chen JA, Gessler FA, Arnaout O, Valdes PA, Choi BD, Peruzzi PP, Bernstock JD, Chiocca EA.
Translational advancements in tumor vaccine therapies for glioblastomas.
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv72-iv83. doi: 10.1093/noajnl/vdaf051. PMID: 40933034. Review. ˍ